Volume 89, Issue 4
  • ISSN: 0002-9637
  • E-ISSN: 1476-1645



Approximately 2–7% of the Omani population has chronic hepatitis B virus (HBV) infection. To decrease this burden, universal childhood hepatitis B vaccination was introduced in Oman in 1990. The hepatitis B vaccination strategy and reported coverage were reviewed. To assess the impact of the program on chronic HBV seroprevalence, a nationally representative seroprevalence study was conducted in Oman in 2005. Since 1991, hepatitis B vaccination in Oman has reached almost every eligible child, with reported coverage of ≥ 97% for the birth dose and ≥ 94% for three doses. Of 175 children born pre-vaccine introduction, 16 (9.1%) had evidence of HBV exposure, and 4 (2.3%) had evidence of chronic infection. Of 1,890 children born after vaccine introduction, 43 (2.3%) had evidence of HBV exposure, and 10 (0.5%) had evidence of chronic infection. Oman has a strong infant hepatitis B vaccination program, resulting in a dramatic decrease in chronic HBV seroprevalence.


Article metrics loading...

Loading full text...

Full text loading...



  1. WHO, 2004. Hepatitis B vaccines. Wkly Epidemiol Rec 79: 255263.
  2. Ott JJ, Stevens GA, Groeger J, Wiersma ST, , 2012. Global epidemiology of hepatitis B virus infection: new estimates of age-specific HBsAg seroprevalence and endemicity. Vaccine 30: 22122219.[Crossref]
  3. Regional Committee for the Eastern Mediterranean, 2009. Resolution: the growing threats of hepatitis B and C in the Eastern Mediterranean Region: a call for action. EM/RC56/R.5.
  4. CDC, 2011. World Hepatitis Day. Available at: http://www.cdc.gov/Features/dsHepatitisAwareness/. Accessed August 2, 2011.
  5. Ministry of Health-Oman, 2009. Annual Health Report. Available at: http://www.moh.gov.om/en/stat/2009/index_eng.htm. Accessed December 1, 2012.
  6. Al Awaidy S, Abu-Elyazeed R, Al Hosani H, Al Mulla A, Al Busaiedy S, Al Amiry A, Farah Z, Al Marrie A, Bock HL, Al-Shaar I, Shah S, , 2006. Sero-epidemiology of hepatitis B infection in pregnant women in Oman, Qatar and the United Arab Emirates. J Infect 52: 202206.[Crossref]
  7. Ministry of Health-Oman, 2010. Annual Health Report. Available at: http://www.moh.gov.om/en/stat/2010/Chapters/CH08Y10.pdf. Accessed December 1, 2012.
  8. Ministry of Health-Oman, 2006. Annual Health Report. Available at: http://www.moh.gov.om/en/stat/2006/Chapters/CH8Y06.pdf. Accessed December 1, 2012.
  9. Department of Family & Community Health Programmes, Department of Surveillance & Disease Control, 1993. Viral hepatitis: current status in the Sultanate. Community Health & Disease Surveillance Newsletter H: 14.
  10. Ministry of Health-Oman, 2005. Oman viral hepatitis survey: 2005. Community Health and Disease Surveillance Newsletter 14: 13, 910.
  11. Goldstein ST, Zhou F, Hadler SC, Bell BP, Mast EE, Margolis HS, , 2005. A mathematical model to estimate global hepatitis B disease burden and vaccination impact. Int J Epidemiol 34: 13291339.[Crossref]
  12. Vandelaer J, Bilous J, Nshimirimana D, , 2008. Reaching Every District (RED) approach: a way to improve immunization performance. Bull World Health Organ 86: AB.[Crossref]
  13. WHO, 2011. Documenting the Impact of Hepatitis B Immunization: Best Practices for Conducting a Serosurvey. Geneva: World Health Organization.
  14. World Health Organization, 2011. Immunization Profile - Oman. Available at: http://apps.who.int/immunization_monitoring/en/globalsummary/countryprofileselect.cfm. Accessed January 1, 2012.
  15. Ministry of Health-Oman, 2002. Frequently asked questions (FAQ): hepatitis B. Community Health and Disease Surveillance Newsletter 11: 8.
  16. Ministry of Health-Oman, 2003. Coverage of target groups (1985 & 1986 birth cohorts) by region/governorate: hepatitis B catch-up immunization campaign in schools: 2002–03. Community Health and Disease Surveillance Newsletter 12: 7.
  17. WHO/UNICEF, 2009. Review of Immunization Coverage-Oman: 1980–2008. Geneva: World Health Organization, UNICEF.
  18. WHO-EMRO, 2010. Country Profile: Oman. Available at: http://www.emro.who.int/emrinfo/index.aspx?Ctry=oma. Accessed August 2, 2011.
  19. Kao JH, Chen DS, , 2002. Global control of hepatitis B virus infection. Lancet Infect Dis 2: 395403.[Crossref]
  20. Mast EE, Weinbaum CM, Fiore AE, Alter MJ, Bell BP, Finelli L, Rodewald LE, Douglas JM, Jr Janssen RS, Ward JW, Advisory Committee on Immunization Practices Centers for Disease C, Prevention, , 2006. A comprehensive immunization strategy to eliminate transmission of hepatitis B virus infection in the United States: recommendations of the Advisory Committee on Immunization Practices (ACIP) Part II: immunization of adults. MMWR Recomm Rep 55: 133; quiz CE31–34.
  21. Centers for Disease Control and Prevention, 2007. Progress in hepatitis B prevention through universal infant vaccination–China, 1997–2006. MMWR Morb Mortal Wkly Rep 56: 441445.
  22. Cui F, Li L, Hadler SC, Wang F, Zheng H, Chen Y, Gong X, Hutin YJ, Cairns KL, Liang X, Yang W, , 2010. Factors associated with effectiveness of the first dose of hepatitis B vaccine in China: 1992–2005. Vaccine 28: 59735978.[Crossref]
  23. Liang X, Bi S, Yang W, Wang L, Cui G, Cui F, Zhang Y, Liu J, Gong X, Chen Y, Wang F, Zheng H, Guo J, Jia Z, Ma J, Wang H, Luo H, Li L, Jin S, Hadler SC, Wang Y, , 2009. Evaluation of the impact of hepatitis B vaccination among children born during 1992–2005 in China. J Infect Dis 200: 3947.[Crossref]
  24. Creati M, Saleh A, Ruff TA, Stewart T, Otto B, Sutanto A, Clements CJ, , 2007. Implementing the birth dose of hepatitis B vaccine in rural Indonesia. Vaccine 25: 59855993.[Crossref]

Data & Media loading...

  • Received : 05 Jun 2013
  • Accepted : 24 Jul 2013

Most Cited This Month

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error